Loading...
9 South Korea Clinical Trial Services Reports
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Blacktrace Holdings Ltd., Fluigent SA , Halma Plc , Precigenome LLC , PerkinElmer Inc.
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: MedNet Solutions Inc., IBM, Calyx, Oracle , Advarra
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Bristol-Myers Squibb Company, Covance Inc., IQVIA, Pharmaceutical Product Development, LLC, Syneos Health Inc.
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Laboratory Corporation of America, Caidya, ICON plc, Lilly, IQVIA Inc
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Iqvia Holdings Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Eli Lilly and Company, Novo Nordisk A/S
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Novartis AG, Merck & Co Inc., F Hoffmann-La Roche Ltd, Pfizer Inc., Bristol Myers Squibb Company
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Novadiscovery, Insilico Medicine, Inc., GNS Healthcare , Immunetrics Inc., InSilicoTrials Technologies
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: AbbVie Inc., Biogen, Merck & Co., Inc., Novartis AG, Sanofi
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Thermo Fisher Scientific, Catalent, Paraxel, Almac Group, Marken